Evidence map›Paper›PMID 28395666›Full record

ArticleLipids in health and disease2017

Hydroxytyrosol prevents reduction in liver activity of Δ-5 and Δ-6 desaturases, oxidative stress, and depletion in long chain polyunsaturated fatty acid content in different tissues of high-fat diet fed mice.

Rodrigo Valenzuela, Francisca Echeverria, Macarena Ortiz, Miguel Ángel Rincón-Cervera, Alejandra Espinosa, María Catalina Hernandez-Rodas, Paola Illesca, Alfonso Valenzuela, Luis A Videla

Open access · goldAbstract read
In one paragraph

Article in Lipids in health and disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
8.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 104 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Hydroxytyrosol produced by engineeredExperimental biology and medicine (Maywood, N.J.) · 2023
    Article
  9. Review
  10. Potential Harm of IQOS Smoke to Rat Liver.International journal of molecular sciences · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Rodrigo ValenzuelaNutrition Department, Faculty of Medicine, University of Chile, Independencia 1027, Casilla, 70000, Santiago 7, Chile. rvalenzuelab@med.uchile.cl.
Francisca EcheverriaNutrition Department, Faculty of Medicine, University of Chile, Independencia 1027, Casilla, 70000, Santiago 7, Chile.
Macarena OrtizNutrition Department, Faculty of Medicine, University of Chile, Independencia 1027, Casilla, 70000, Santiago 7, Chile.
Miguel Ángel Rincón-CerveraLipid Center, Institute of Nutrition and Food Technology (INTA), University of Chile, Santiago, Chile.
Alejandra EspinosaMedical Technology Department, Faculty of Medicine, University of Chile, Santiago, Chile.
María Catalina Hernandez-RodasNutrition Department, Faculty of Medicine, University of Chile, Independencia 1027, Casilla, 70000, Santiago 7, Chile.
Paola IllescaBiochemistry Department. Faculty of Biochemistry, University of Litoral, Santa Fe, Argentina.
Alfonso ValenzuelaLipid Center, Institute of Nutrition and Food Technology (INTA), University of Chile, Santiago, Chile.
Luis A VidelaMolecular and Clinical Pharmacology Program, Institute of Biomedical Science, Faculty of Medicine, University of Chile, Santiago, Chile.
University of Chile · CLNational University of the Littoral · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEicosapentaenoic acid (EPA, C20:5n-3), docosahexaenoic acid (DHA, C22:6n-3) and arachidonic acid (AA, C20:4n-6) are long-chain polyunsaturated fatty acids (LCPUFAs) with relevant roles in the organism. EPA and DHA are synthesized from the precursor alpha-linolenic acid (ALA, C18:3n-3), whereas AA is produced from linoleic acid (LA, C18:2n-6) through the action of Δ5 and Δ6-desaturases. High-fat diet (HFD) decreases the activity of both desaturases and LCPUFA accretion in liver and other tissues. Hydroxytyrosol (HT), a natural antioxidant, has an important cytoprotective effects in different cells and tissues.

methodsMale mice C57BL/6 J were fed a control diet (CD) (10% fat, 20% protein, 70% carbohydrates) or a HFD (60% fat, 20% protein, 20% carbohydrates) for 12 weeks. Animals were daily supplemented with saline (CD) or 5 mg HT (HFD), and blood and the studied tissues were analyzed after the HT intervention. Parameters studied included liver histology (optical microscopy), activity of hepatic desaturases 5 and 6 (gas-liquid chromatography of methyl esters derivatives) and antioxidant enzymes (catalase, superoxide dismutase, glutathione peroxidase, and glutathione reductase by spectrophotometry), oxidative stress indicators (glutathione, thiobarbituric acid reactants, and the antioxidant capacity of plasma), gene expression assays for sterol regulatory element-binding protein 1c (SREBP-1c) (qPCR and ELISA), and LCPUFA profiles in liver, erythrocyte, brain, heart, and testicle (gas-liquid chromatography).

resultsHFD led to insulin resistance and liver steatosis associated with SREBP-1c upregulation, with enhancement in plasma and liver oxidative stress status and diminution in the synthesis and storage of n-6 and n-3 LCPUFAs in the studied tissues, compared to animals given control diet. HT supplementation significantly reduced fat accumulation in liver and plasma as well as tissue metabolic alterations induced by HFD. Furthermore, a normalization of desaturase activities, oxidative stress-related parameters, and tissue n-3 LCPUFA content was observed in HT-treated rats over control animals.

conclusionsHT supplementation prevents metabolic alterations in desaturase activities, oxidative stress status, and n-3 LCPUFA content in the liver and extrahepatic tissues of mice fed HFD.

Indexed as

Dietary SupplementsAnimalsAntioxidantsBiomarkersDelta-5 Fatty Acid DesaturaseDiet, High-FatFatty Acid DesaturasesFatty Acids, Omega-3Fatty Acids, Omega-6HydroxylationInsulin ResistanceLinoleoyl-CoA DesaturaseLiverMaleMice, Inbred C57BLNon-alcoholic Fatty Liver Disease3,4-dihydroxyphenylethanolAntioxidantsBiomarkersDelta-5 Fatty Acid DesaturaseFatty Acid DesaturasesFatty Acids, Omega-3Fatty Acids, Omega-6Linoleoyl-CoA DesaturasePhenylethyl AlcoholAntioxidant capacityHydroxytyrosolLCPUFALiver and extrahepatic tissuesOxidative stressΔ5/Δ6 Desaturase activity

Identifiers

PMID28395666
PMCPMC5387240
OpenAlexW2601145837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.